Global EndocrineTesting Market, By Test (Thyroid, Insulin, Follicle Stimulating Hormone,Luteinizing, Hormone, Estradiol, Testosterone, Human Chorionic Gonadotropin,Prolactin, Cortisol DHEA-S, Others) By Diagnostic Technology ( Immunoassay,Tandem Mass Spectrometry, Monoclonal and Polyclonal antibodies, SensorsTechnologies, Clinical Chemistry , Others), By End User (Hospitals and DiagnosticLaboratories, Others), and By Region (North America, Latin America, Europe,Asia Pacific, Middle East, and Africa), is estimated to be valued at US$3,403.0 million in 2020 and is expected to exhibit a CAGR of 5.3 % over theforecast period (2020-2027), as highlighted in a new report published byCoherent Market Insights.
Key companies are focusing onproduct developments for testing of diabetes mellitus, one of the most commonendocrinal disorders, globally. For instance, in 2018, Roche Diabetes CareIndia, a leading company in monitoring diabetes with their testing kits, launcheda novel self- monitoring glucometer Accu-Chek Instant S for testing of glucoselevels in blood of diabetic patients.
Moreover, companies are highlyfocused on innovation and advancements in rapid testing and diagnosis ofdiabetes to strengthen their market share in the global endocrine testingmarket. For instance, in 2019, iQ Group Global launched an innovativetechnology in saliva based glucose testing for diagnosis and testing theglucose level in blood.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/1755
Global Endocrine Testing Market –Impact of Coronavirus (Covid-19) Pandemic
Due to the lockdown, diabeticpatients are unable to visit diagnostic laboratories due to risk of diabeticpatients getting infected by COVID-19 infections. Therefore, safety proceduressuch as maintaining social distancing, proper management of blood spills whilecollecting blood samples, and use of personal protection equipment must befollowed and evaluated for patients having diabetic conditions, as diabeticpatients are more prone towards the risk of COVID-19 infection..
According to Journal ofReproductive Science report in 2020, fundamental principles such as socialdistancing and use of personal protection equipment should be followed byclinicians of diagnostics laboratories while performing testing procedures onpatients
According to Indian Society ofAssisted Reproduction report in 2020, while conducting semen analysis, itshould be ensured that the male candidate is COVID-19 negative by reversetranscription polymerase chain reaction (RT-PCR)
Browse 45 Market Data Tables and35 Figures spread through 200 pages and in-depth TOC on “Global EndocrineTesting Market, By Test ( Thyroid, Insulin, Follicle Stimulating Hormone,Luteinizing, Hormone, Estradiol, Testosterone, Human Chorionic Gonadotropin,Prolactin, Cortisol DHEA-S, Others) By Diagnostic Technology ( Immunoassay,Tandem Mass Spectrometry, Monoclonal and Polyclonal antibodies, SensorsTechnologies, Clinical Chemistry , Others), By End User (Hospitals andDiagnostic Laboratories, Others), and By Region (North America, Latin America,Europe, Asia Pacific, Middle East, and Africa),
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/endocrine-testing-market-1755
The market is expected to gainsignificant growth during the forecast period, as various companies arefocusing on research and development in the field of endocrine testing.
For instance, in 2018, MiraCarelaunched TechCrunch Disrupt SF, a novel self-monitoring fertility testingdevice for women who are suffering from fertility problems. TechCrunch DisruptSF is a personalized self-monitoring device used for cycle predication in womenby monitoring fertility hormone through urine samples in females.
Key Takeaways of the GlobalEndocrine Testing Market:
The global endocrine testingmarket is expected to exhibit a CAGR of 5.3 % over the forecast period, owingto robust product pipeline, and increasing approval of new endocrine testingdevices and diagnostic procedures
Among test , insulin and thyroidsegments are estimated to hold dominant position in the endocrine testingmarket in 2020, owing to rising prevalence of diabetes and thyroid relateddisorders (hypothyroidism and hyperthyroidism)
Among diagnosis technology type,sensor technologies endocrine testing market segment is estimated to holddominant position in the endocrine testing market in 2020, due to risetechnological advancements and increasing prevalence of endocrine related disorders
Among end user, diagnosticlaboratories market segment is estimated to hold dominant position in theendocrine testing market in 2020, owing to rising diagnostic procedures due tohigh number of individuals suffering from fertility, diabetes, and thyroidrelated conditions
Key players operating in globalendocrine testing market include Abbott Laboratories, Thermo Fisher Scientific,Bio-Rad Laboratories, Inc., Beckmann Coulter, Inc., Agilent Technologies, Inc,Siemens Healthineers AG, BioMérieux SA, Quest Diagnostics, and F. Hoffmann-LaRoche AG.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/1755
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
